Veuillez vous connecter pour utiliser cette fonctionnalité.
Contactez votre distributeur local :
Téléphone : +1 850 650 7790
The store will not work correctly when cookies are disabled.
Menu
Account
Home
Signaling Pathways
Neuroscience
Alzheimer
Amyloid Beta-Peptide (12-28) (human)
Home
Signaling Pathways
Neuroscience
Amyloid β
Amyloid Beta-Peptide (12-28) (human)
Home
Signaling Pathways
Neuroscience
Neuroscience Peptides
Amyloid Beta-Peptide (12-28) (human)
Home
Peptides
Aβ
Amyloid Beta-Peptide (12-28) (human)
Amyloid Beta-Peptide (12-28) (human)
Skip to the end of the images gallery
Skip to the beginning of the images gallery
Featured Products
mRNA synthesis
In vitro transcription of capped mRNA with modified nucleotides and Poly(A) tail
Tyramide Signal Amplification (TSA)
TSA (Tyramide Signal Amplification), used for signal amplification of ISH, IHC and IC etc.
Phos Binding Reagent Acrylamide
Separation of phosphorylated and non-phosphorylated proteins without phospho-specific antibody
Cell Counting Kit-8 (CCK-8)
A convenient and sensitive way for cell proliferation assay and cytotoxicity assay
Inhibitor Cocktails
Protect the integrity of proteins from multiple proteases and phosphatases for different applications.
Background
Amyloid beta (Aβ or Abeta) is a peptide of 36–43 amino acids that is processed from the Amyloid precursor protein. While best known as a component of amyloid plaques in association with Alzheimer's disease, evidence has been found that Aβ is a highly multifunctional peptide with significant non-pathological activity(1). Aβ is the main component of deposits found in the brains of patients with Alzheimer's disease. Brain Aβ is elevated in patients with sporadic Alzheimer’s disease. Aβ is the main constituent of brain parenchymal and vascular amyloid, it contributes to cerebrovascular lesions and is neurotoxic(2).
Figure1 Formula of Amyloid β-Peptide (12-28) (human)
Figure2 signal pathway of Amyloid β
Ref:
1. Lahiri DK, Maloney B (September 2010). "Beyond the signaling effect role of amyloid–β42 on the processing of AβPP, and its clinical implications". Exp. Neurol. 225 (1): 51–4.
2. Hardy J, Duff K, Hardy KG, Perez-Tur J, Hutton M (September 1998). "Genetic dissection of Alzheimer's disease and related dementias: amyloid and its relationship to tau". Nat. Neurosci. 1 (5): 355–8.